Funding for this research was provided by:
Coca-Cola Foundation (404905/2016-1)
Received: 28 May 2021
Accepted: 29 July 2021
First Online: 26 August 2021
: Not applicable.
: Ethical approval was provided by the Western Institutional Review Board (#20140605), and by the ethical review boards of the participating institutions. ELANS is registered at Clinical Trials #NCT02226627. Written informed consent/assent was obtained from all individuals, before commencement of the study.
: M.F. has received fees and consultancy payments from biotechnology, pharmaceutical and food and beverage companies. He has also received fees, payments for consulting and financing research studies without any restrictions, from government sources and non-profit entities. The rest of the authors also have no conflicts of interest to declare. None of the entities mentioned had or have any role in the design or preparation of this manuscript.